News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
843,266 Results
Type
Article (86305)
Company Profile (655)
Press Release (756306)
Section
Business (232594)
Career Advice (4125)
Deals (39710)
Drug Delivery (128)
Drug Development (90940)
Employer Resources (198)
FDA (18075)
Job Trends (17318)
News (396277)
Policy (39704)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (7)
2025 BioForest Digital (7)
2025 Lone Star Bio Digital (10)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2993)
Academic (1)
Accelerated approval (5)
Adcomms (29)
Allergies (88)
Alliances (56765)
ALS (93)
Alzheimer's disease (1479)
Antibody-drug conjugate (ADC) (141)
Approvals (18040)
Artificial intelligence (282)
Autoimmune disease (22)
Automation (14)
Bankruptcy (404)
Best Places to Work (12633)
BIOSECURE Act (21)
Biosimilars (115)
Biotechnology (450)
Bladder cancer (65)
Brain cancer (30)
Breast cancer (275)
Cancer (2176)
Cardiovascular disease (189)
Career advice (3530)
Career pathing (33)
CAR-T (161)
Cell therapy (453)
Cervical cancer (21)
Clinical research (73121)
Collaboration (842)
Compensation (482)
Complete response letters (30)
COVID-19 (2858)
CRISPR (43)
C-suite (232)
Cystic fibrosis (105)
Data (2039)
Decentralized trials (2)
Denatured (43)
Depression (50)
Diabetes (275)
Diagnostics (6884)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (126)
Drug pricing (122)
Drug shortages (33)
Duchenne muscular dystrophy (93)
Earnings (96223)
Editorial (40)
Employer branding (25)
Employer resources (167)
Events (129271)
Executive appointments (692)
FDA (19265)
Featured Employer (64)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (751)
Gene editing (111)
Generative AI (28)
Gene therapy (327)
GLP-1 (825)
Government (5121)
Grass and pollen (5)
Guidances (49)
Healthcare (20878)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (131)
Indications (27)
Infectious disease (3007)
Inflammatory bowel disease (148)
Inflation Reduction Act (11)
Influenza (53)
Intellectual property (91)
Interviews (812)
IPO (17794)
IRA (51)
Job creations (5184)
Job search strategy (2861)
Kidney cancer (10)
Labor market (38)
Layoffs (541)
Leadership (21)
Legal (10102)
Liver cancer (76)
Lung cancer (317)
Lymphoma (139)
Machine learning (4)
Management (65)
Manufacturing (307)
MASH (68)
Medical device (14573)
Medtech (14578)
Mergers & acquisitions (22393)
Metabolic disorders (730)
Multiple sclerosis (79)
NASH (23)
Neurodegenerative disease (103)
Neuropsychiatric disorders (31)
Neuroscience (2025)
NextGen: Class of 2025 (7667)
Non-profit (5077)
Northern California (2522)
Now hiring (38)
Obesity (397)
Opinion (270)
Ovarian cancer (75)
Pain (90)
Pancreatic cancer (79)
Parkinson's disease (148)
Partnered (22)
Patents (221)
Patient recruitment (101)
Peanut (51)
People (65078)
Pharmaceutical (134)
Pharmacy benefit managers (21)
Phase I (22557)
Phase II (31747)
Phase III (23939)
Pipeline (1107)
Podcasts (122)
Policy (141)
Postmarket research (3552)
Preclinical (10129)
Press Release (72)
Prostate cancer (99)
Psychedelics (38)
Radiopharmaceuticals (267)
Rare diseases (406)
Real estate (7386)
Recruiting (75)
Regulatory (26660)
Reports (57)
Research institute (2654)
Resumes & cover letters (649)
Rett syndrome (4)
RNA editing (4)
RSV (47)
Schizophrenia (76)
Series A (133)
Series B (84)
Service/supplier (27)
Sickle cell disease (57)
Southern California (2193)
Special edition (18)
Spinal muscular atrophy (166)
Sponsored (33)
Startups (4286)
State (2)
Stomach cancer (16)
Supply chain (67)
Tariffs (14)
The Weekly (77)
United States (22855)
Vaccines (775)
Venture capitalists (39)
Webinars (13)
Weight loss (291)
Women's health (38)
Worklife (19)
Date
Today (62)
Last 7 days (699)
Last 30 days (2746)
Last 365 days (36076)
2025 (8989)
2024 (37955)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (56)
Alaska (7)
Arizona (261)
Arkansas (14)
Asia (49982)
Australia (8811)
California (5870)
Canada (1923)
China (510)
Colorado (264)
Connecticut (281)
Delaware (138)
Europe (114554)
Florida (854)
Georgia (209)
Hawaii (1)
Idaho (64)
Illinois (587)
India (28)
Indiana (317)
Iowa (10)
Japan (147)
Kansas (108)
Kentucky (27)
Louisiana (13)
Maine (69)
Maryland (909)
Massachusetts (4548)
Michigan (234)
Minnesota (400)
Mississippi (2)
Missouri (87)
Montana (31)
Nebraska (26)
Nevada (58)
New Hampshire (68)
New Jersey (1679)
New Mexico (31)
New York (1673)
North Carolina (1076)
North Dakota (8)
Northern California (2522)
Ohio (207)
Oklahoma (15)
Oregon (45)
Pennsylvania (1304)
Puerto Rico (10)
Rhode Island (30)
South America (1650)
South Carolina (19)
South Dakota (1)
Southern California (2193)
Tennessee (98)
Texas (882)
Utah (175)
Virginia (152)
Washington D.C. (65)
Washington State (563)
West Virginia (3)
Wisconsin (61)
843,266 Results for "shangdong simcere medgenn bio pharmaceutical co ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioCity Biopharmaceutics Co., Ltd. Announces Clinical Collaboration to Evaluate BC3195 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced or Metastatic Solid Tumors
March 13, 2025
·
3 min read
Press Releases
Merck Enters Exclusive License Agreement for HRS-5346, an Investigational Oral Lipoprotein(a) Inhibitor, for Cardiovascular Disease from Jiangsu Hengrui Pharmaceuticals Co., Ltd.
March 25, 2025
·
5 min read
Press Releases
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing
Company executives will host a corporate webinar for investors and stakeholders on Thursday, April 10, 2025
March 31, 2025
·
12 min read
Press Releases
WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
March 3, 2025
·
5 min read
Business
Connect Biopharma and Simcere Announce Exclusive Licensing and Collaboration Agreement in Greater China
Connect Biopharma Holdings Limited announced that two of its wholly owned subsidiaries, Connect Biopharma Hong Kong Limited and Suzhou Connect Biopharma Co., Ltd., have entered into an exclusive license and collaboration agreement with Simcere Pharmaceutical Co., Ltd., a subsidiary of Simcere Pharmaceutical Group Ltd., to develop and commercialize Connect Biopharma’s rademikibart in Greater China.
November 21, 2023
·
6 min read
Press Releases
Pierre Fabre Laboratories and RedRidge Bio Announce a Drug Discovery and Co-development Partnership
March 12, 2025
·
2 min read
Immunology and inflammation
Hillstar Bio Nets $67M Series A to Advance Autoimmune and Arthritis Pipeline
Led by alums from Takeda and Boston Pharmaceuticals, Hillstar Bio is working on treatments that remove harmful immune cells to relieve disease.
March 25, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Fermion and Simcere Enter into an Exclusive License and Collaboration Agreement for China’s First SSTR4 Agonist Targeting Pain
January 19, 2025
·
3 min read
Press Releases
Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering
December 31, 2024
·
4 min read
Press Releases
Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering
December 26, 2024
·
4 min read
1 of 84,327
Next
